{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:12:02Z","timestamp":1787314322293,"version":"build-2736575974"},"reference-count":72,"publisher":"SAGE Publications","issue":"1_suppl","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"name":"UCB Canada Inc."}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Cutan Med Surg"],"published-print":{"date-parts":[[2022,7]]},"abstract":"<jats:p>The IL-17 signalling pathway is a major target in treatment of plaque psoriasis. IL-17 signalling contributes to chronic inflammation and epidermal hyperplasia seen in psoriatic lesions. Blocking the IL-17 signalling cascade is an effective method in treating this disease. However, IL-17 also plays a role in the immunological protection against fungal infections and therefore, patients on IL-17 biologics experience an increased rate of fungal infections, specifically Candida albicans. It is prudent that patients and physicians are aware of this risk and understand how to recognize and manage Candida infections. In this review, we examine the Candida infection rates associated with IL-17 biologics, both in clinical trials and real-world practice. We discuss common presentations associated with various types of candidiasis and propose a recommended management approach to treating these infections.<\/jats:p>","DOI":"10.1177\/12034754221111111","type":"journal-article","created":{"date-parts":[[2022,7,12]],"date-time":"2022-07-12T08:10:37Z","timestamp":1657613437000},"page":"3S-23S","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":17,"title":["Review and Practical Guidance on Managing Fungal Infections in Patients With Psoriasis Receiving Anti-IL-17 Therapies"],"prefix":"10.1177","volume":"26","author":[{"given":"Jensen","family":"Yeung","sequence":"first","affiliation":[{"name":"Faculty of Medicine, University of Toronto, Toronto, ON, Canada"},{"name":"Division of Dermatology, Department of Medicine, University of Toronto, Toronto, ON, Canada"},{"name":"Sunnybrook Health Sciences Centre, Toronto, ON, Canada"},{"name":"Department of Dermatology, Women\u2019s College Hospital, Toronto, ON, Canada"},{"name":"Probity Medical Research Inc., Waterloo, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul E.","family":"Bunce","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, University of Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9163-5463","authenticated-orcid":false,"given":"Charles W.","family":"Lynde","sequence":"additional","affiliation":[{"name":"Division of Dermatology, Department of Medicine, University of Toronto, Toronto, ON, Canada"},{"name":"Probity Medical Research Inc., Waterloo, ON, Canada"},{"name":"Lynde Institute for Dermatology, Markham, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8654-9050","authenticated-orcid":false,"given":"Irina","family":"Turchin","sequence":"additional","affiliation":[{"name":"Probity Medical Research Inc., Waterloo, ON, Canada"},{"name":"Brunswick Dermatology Center, Fredericton, New Brunswick, Canada"},{"name":"Department of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2624-2724","authenticated-orcid":false,"given":"Ronald B.","family":"Vender","sequence":"additional","affiliation":[{"name":"Dermatrials Research Inc. & Venderm Innovations in Psoriasis, Hamilton, ON, Canada, Canada"},{"name":"Division of Dermatology, Department of Medicine, McMaster University, Hamilton, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2022,7,12]]},"reference":[{"key":"bibr1-12034754221111111","doi-asserted-by":"publisher","DOI":"10.1038\/ni1254"},{"key":"bibr2-12034754221111111","doi-asserted-by":"publisher","DOI":"10.1038\/ni1261"},{"key":"bibr3-12034754221111111","doi-asserted-by":"publisher","DOI":"10.1016\/j.rdc.2015.07.013"},{"key":"bibr4-12034754221111111","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-065X.2008.00628.x"},{"key":"bibr5-12034754221111111","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2011.02.012"},{"key":"bibr6-12034754221111111","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M700499200"},{"key":"bibr7-12034754221111111","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2013.477"},{"key":"bibr8-12034754221111111","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00746"},{"key":"bibr9-12034754221111111","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2010.340"},{"key":"bibr10-12034754221111111","doi-asserted-by":"publisher","DOI":"10.1111\/exd.13750"},{"key":"bibr11-12034754221111111","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1001001"},{"key":"bibr12-12034754221111111","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2008.139"},{"key":"bibr13-12034754221111111","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2008.11.009"},{"key":"bibr14-12034754221111111","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20081463"},{"key":"bibr15-12034754221111111","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-809633-8.12077-1"},{"key":"bibr16-12034754221111111","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-08360-9"},{"key":"bibr17-12034754221111111","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1314258"},{"key":"bibr18-12034754221111111","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2015.04.011"},{"key":"bibr19-12034754221111111","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.15706"},{"key":"bibr20-12034754221111111","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.13348"},{"issue":"10","key":"bibr21-12034754221111111","first-page":"1226","volume":"15","author":"Gottlieb AB.","year":"2016","journal-title":"J Drugs Dermatol"},{"key":"bibr22-12034754221111111","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.12751"},{"key":"bibr23-12034754221111111","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.14073"},{"key":"bibr24-12034754221111111","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1512711"},{"key":"bibr25-12034754221111111","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)60125-8"},{"key":"bibr26-12034754221111111","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2020.11.022"},{"key":"bibr27-12034754221111111","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.14493"},{"key":"bibr28-12034754221111111","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1503824"},{"key":"bibr29-12034754221111111","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.19132"},{"key":"bibr30-12034754221111111","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2019.05.095"},{"key":"bibr31-12034754221111111","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00126-4"},{"key":"bibr32-12034754221111111","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2102383"},{"key":"bibr33-12034754221111111","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2102388"},{"key":"bibr34-12034754221111111","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00125-2"},{"key":"bibr35-12034754221111111","doi-asserted-by":"publisher","DOI":"10.25251\/skin.6.supp.68"},{"key":"bibr36-12034754221111111","unstructured":"Leonardi C., Sator P., Morita A et al. Bimekizumab efficacy and safety up to two years in patients with moderate to severe plaque psoriasis switching from ustekinumab: results from the interim BE BRIGHT open-label extension trial. presented at: EADV. 2021."},{"key":"bibr37-12034754221111111","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2018.05.599"},{"key":"bibr38-12034754221111111","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-019-1882-2"},{"key":"bibr39-12034754221111111","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.16124"},{"key":"bibr40-12034754221111111","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2016.09.026"},{"key":"bibr41-12034754221111111","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.15723"},{"key":"bibr42-12034754221111111","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaa189"},{"key":"bibr43-12034754221111111","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-019-00340-3"},{"key":"bibr44-12034754221111111","doi-asserted-by":"publisher","DOI":"10.25251\/skin.5.supp.21"},{"key":"bibr45-12034754221111111","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2021.100266"},{"key":"bibr46-12034754221111111","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2018.1528000"},{"key":"bibr47-12034754221111111","doi-asserted-by":"publisher","DOI":"10.1080\/14712598.2020.1708897"},{"key":"bibr48-12034754221111111","doi-asserted-by":"publisher","DOI":"10.1002\/pds.5132"},{"key":"bibr49-12034754221111111","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-020-00472-x"},{"key":"bibr50-12034754221111111","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.15015"},{"key":"bibr51-12034754221111111","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.16073"},{"issue":"5","key":"bibr52-12034754221111111","first-page":"545","volume":"156","author":"Rodr\u00edguez-Cerdeira C.","year":"2021","journal-title":"Ital J Dermatol Venerol"},{"key":"bibr53-12034754221111111","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2021.100266"},{"key":"bibr54-12034754221111111","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-016-0206-4"},{"key":"bibr55-12034754221111111","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2021.08.081"},{"key":"bibr56-12034754221111111","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/civ933"},{"key":"bibr57-12034754221111111","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.15782"},{"key":"bibr58-12034754221111111","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2021.107925"},{"key":"bibr59-12034754221111111","doi-asserted-by":"publisher","DOI":"10.2147\/JIR.S100940"},{"key":"bibr60-12034754221111111","volume-title":"(brodalumab) [package insert]","author":"SILIQ\u2122","year":"2017"},{"key":"bibr61-12034754221111111","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-016-0121-x"},{"key":"bibr62-12034754221111111","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01894"},{"key":"bibr63-12034754221111111","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2017.06.153"},{"key":"bibr64-12034754221111111","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2021.06.270"},{"issue":"6","key":"bibr65-12034754221111111","first-page":"595","volume":"42","author":"Ferris DG.","year":"1996","journal-title":"J Fam Pract"},{"key":"bibr66-12034754221111111","volume-title":"(clotrimazole and betamethasone dipropionate)","author":"LOTRISONE\u00ae","year":"2007"},{"key":"bibr67-12034754221111111","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.rr7004a1"},{"key":"bibr68-12034754221111111","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.325.7355.77"},{"key":"bibr69-12034754221111111","volume-title":"[package insert]","author":"NYSTATIN","year":"2018"},{"key":"bibr70-12034754221111111","volume-title":"(terbinafine) [package insert]","author":"LAMISIL\u00ae"},{"key":"bibr71-12034754221111111","volume-title":"(ciclopirox) [package insert]","author":"LOPROX\u00ae","year":"2013"},{"key":"bibr72-12034754221111111","volume-title":"(fluconazole) [package insert]","author":"DIFLUCAN\u00ae","year":"2011"}],"container-title":["Journal of Cutaneous Medicine and Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/12034754221111111","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/12034754221111111","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/12034754221111111","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T15:49:26Z","timestamp":1777391366000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/12034754221111111"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":72,"journal-issue":{"issue":"1_suppl","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["10.1177\/12034754221111111"],"URL":"https:\/\/doi.org\/10.1177\/12034754221111111","relation":{},"ISSN":["1203-4754","1615-7109"],"issn-type":[{"value":"1203-4754","type":"print"},{"value":"1615-7109","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7]]}}}